Common Contracts

23 similar null contracts by aTYR PHARMA INC, Biocept Inc, Kaival Brands Innovations Group, Inc., others

XCEL BRANDS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of ________, 20__ Debt Securities
XCel Brands, Inc. • January 26th, 2024 • Patent owners & lessors • New York
AutoNDA by SimpleDocs
DUTCH BROS INC. AND _____________, AS TRUSTEE FORM OF INDENTURE DATED AS OF __________ Debt Securities
Dutch Bros Inc. • September 6th, 2023 • Retail-eating & drinking places • New York

THIS INDENTURE, dated as of [], between DUTCH BROS INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):

INDENTURE Dated as of [•], 20__ Debt Securities
Bionano Genomics, Inc. • March 10th, 2023 • Laboratory analytical instruments • New York

Indenture, dated as of [•], 20__, among Bionano Genomics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):

FEMASYS INC., AS ISSUER, AND [TRUSTEE], AS TRUSTEE, INDENTURE DATED AS OF , 20 DEBT SECURITIES
Femasys Inc • July 1st, 2022 • Surgical & medical instruments & apparatus • New York

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

aTyr Pharma, INC., Issuer AND [TRUSTEE], Trustee
aTYR PHARMA INC • March 15th, 2022 • Biological products, (no disgnostic substances) • New York

Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

aTyr Pharma, INC., Issuer AND [TRUSTEE], Trustee
aTYR PHARMA INC • August 11th, 2021 • Biological products, (no disgnostic substances) • New York

Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

KAIVAL BRANDS INNOVATIONS GROUP, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES
Kaival Brands Innovations Group, Inc. • July 30th, 2021 • Blank checks • New York

INDENTURE, dated as of [●], 20[●], among Kaival Brands Innovations Group, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):

KAIVAL BRANDS INNOVATIONS GROUP, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES
Kaival Brands Innovations Group, Inc. • July 30th, 2021 • Blank checks • New York

INDENTURE, dated as of [£], 20[£], among Kaival Brands Innovations Group, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):

INDENTURE Dated as of [•], 20__ Debt Securities
Bionano Genomics, Inc • January 19th, 2021 • Laboratory analytical instruments • New York

Indenture, dated as of [•], 20__, among Bionano Genomics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):

LIMINAL BIOSCIENCES INC., Issuer AND [TRUSTEE], Trustee
Liminal BioSciences Inc. • December 1st, 2020 • Pharmaceutical preparations • New York
aTyr Pharma, INC., Issuer AND [TRUSTEE], Trustee
aTYR PHARMA INC • November 16th, 2020 • Biological products, (no disgnostic substances) • New York

Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

S&W SEED COMPANY, Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt Securities
S&W Seed Co • September 23rd, 2020 • Agricultural production-crops • New York
Mirum Pharmaceuticals, INC., Issuer AND [TRUSTEE], Trustee
Mirum Pharmaceuticals, Inc. • August 3rd, 2020 • Pharmaceutical preparations • New York
BIOCEPT, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt Securities
Biocept Inc • April 24th, 2020 • Services-medical laboratories • New York
Miragen Therapeutics, Inc., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt Securities
Miragen Therapeutics, Inc. • March 26th, 2020 • Services-medical laboratories • New York
AMERI HOLDINGS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20__ SUBORDINATED DEBT SECURITIES
AMERI Holdings, Inc. • August 14th, 2019 • Semiconductors & related devices • New York

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of subordinated debt securities (hereinafter referred to as the "Securities"), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

SCYNEXIS, INC, Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt Securities
Scynexis Inc • August 31st, 2018 • Pharmaceutical preparations • New York

Whereas, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;

ABEONA THERAPEUTICS INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of ___________, 20 Debt Securities
Abeona Therapeutics Inc. • June 1st, 2018 • Pharmaceutical preparations • New York

INDENTURE, dated as of _____, 20 ____, among Abeona Therapeutics Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):

BIOCEPT, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt Securities
Biocept Inc • May 15th, 2018 • Services-medical laboratories • New York
APTEVO THERAPEUTICS INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt Securities
Aptevo Therapeutics Inc. • November 13th, 2017 • Pharmaceutical preparations • New York

Indenture, dated as of [•], 20__, among Aptevo Therapeutics Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):

UIL HOLDINGS CORPORATION as the Company and THE BANK OF NEW YORK MELLON as Trustee Subordinated Indenture
Uil Holdings Corp • March 9th, 2015 • Electric services • New York

SUBORDINATED INDENTURE, dated as of , 20 , between UIL Holdings Corporation, a Connecticut corporation, as the Company, and The Bank of New York Mellon, a corporation organized under the laws of the State of New York authorized to conduct a banking business, as Trustee.

AutoNDA by SimpleDocs
SANGSTAT MEDICAL CORPORATION, Issuer AND Trustee INDENTURE Dated as of [ ] Senior Debt Securities
Sangstat Medical Corp • December 28th, 2001 • Biological products, (no disgnostic substances) • New York

INDENTURE, dated as of [ ], among SangStat Medical Corporation, a Delaware corporation (the "Company"), and [ ], as trustee (the "Trustee"):

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!